Take a look at page 19 of this WHO report:
http://www.who-umc.org/graphics/6899.pdf
"In July last year the UMC received a regular batch of ADR reports fromone of our European national centres. What was particular about this submission was the covering letter that stated "Please note that several of the attached reports refer to DRUG X, which is a generic product containing SUBSTANCE Y. We suppose that the reports may originate from the marketing strategy of the main competitor, the marketing authorization holder of the original product DRUG Z. We do not have any proof of our suspicions, but there are several hints for this".
Anyone any ideas what X Y and Z are? A nice Christmas present awaits.......
Hat tip: Anon
No comments:
Post a Comment